SERINE ESTERASES IN HUMAN CYTOLYTIC LYMPHOCYTES
SERINE ESTERASES IN HUMAN CYTOLYTIC LYMPHOCYTES
批准号:
3193047
负责人:
Bo Dupont
金额:
$27.94万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1992-06-30
关键词:
antibody formation cell mediated lymphocytolysis test cellular immunity cytotoxic T lymphocyte enzyme mechanism esterase gene expression genetic library genetic mapping helper T lymphocyte human genetic material tag human subject laboratory mouse laboratory rabbit leukocyte activation /transformation molecular cloning natural killer cells protein structure function radiotracer serine transposon /insertion element western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this proposal is to isolate and characterize genes
encoding serine esterases (SEs) from human natural killer (NK) and
cytotoxic T-lymphocytes (CTL) in order to investigate the role of
these molecules in cellular cytotoxicity. The mechanisms by which
NK cells and CTLs destroy their cellular targets is of fundamental
importance for our understanding of cell mediated immunity. Cell
killing involves contact and binding between killer and target
cells followed in most instances by secretion of the contents of
large cytoplasmic granules from mature cytotoxic lymphocytes.
These granules contain several polypeptides with potential
involvement in cytolysis including a pore-forming protein,
perforin, another cytotoxin which is antigenically related to tumor
necrosis factor and lymphotoxin, nucleolytic factor(s) as well as
several different serine proteases (SEs). The functions of SEs in
cytotoxic cells are unknown, but one possibility is that they may
constitute an intracellular activation pathway for other cytotoxic
molecules (e.g., perforin) analogous to that seen extracellularly
with the SEs of the complement pathway. So far, as many as eight
different but structurally related SEs have been isolated from
murine cytotoxic lymphocytes, however, little if any information
is available regarding the corresponding molecules in man. Thus
we propose to: #1) Clone and characterize cDNA and genomic clones
encoding SEs from human NK cells and CTLs; #2) characterize SE
proteins using prokaryotic expression vectors, purify hybrid
proteins and produce rabbit antisera; #3) Investigate expression
of SE genes in human lymphocyte subsets, their differential
expression during activation of cytotoxic and non-cytotoxic
lymphocytes, and factors involved in the regulation of these genes;
#4) Express individual SE in a biologically active form for
detailed functional studies.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cytolytic effector function is present in resting peripheral T lymphocytes.
静息外周 T 淋巴细胞中存在溶细胞效应功能。
DOI:
10.1093/intimm/4.11.1273
发表时间:
1992
期刊:
International immunology
影响因子:
4.4
作者:
[Geisberg,M, Dupont,B]
通讯作者:
Dupont,B
A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
CD28 在葡萄球菌肠毒素 B 激活 CD4 T 淋巴细胞中的共刺激作用。
DOI:
10.1093/intimm/4.12.1351
发表时间:
1992
期刊:
International immunology
影响因子:
4.4
作者:
[Goldbach-Mansky,R, King,PD, Taylor,AP, Dupont,B]
通讯作者:
Dupont,B
DOI:
10.1084/jem.171.2.545
发表时间:
1990-02-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Trapani JA, Kwon BS, Kozak CA, Chintamaneni C, Young JD, Dupont B]
通讯作者:
Dupont B
Novel putative promoter/enhancer sequences are shared by the mouse and human perforin (Pfp) genes.
小鼠和人穿孔素 (Pfp) 基因共享新的推定启动子/增强子序列。
DOI:
10.1111/j.1399-0039.1990.tb01833.x
发表时间:
1990
期刊:
Tissue antigens
影响因子:
--
作者:
[Trapani,JA, Dupont,B]
通讯作者:
Dupont,B
Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C).
新型人细胞毒性淋巴细胞特异性丝氨酸蛋白酶 cDNA 克隆 (CSP-C) 的表征。
DOI:
10.1111/j.1399-0039.1990.tb01787.x
发表时间:
1990
期刊:
Tissue antigens
影响因子:
--
作者:
[Klein,JL, Selvakumar,A, Trapani,JA, Dupont,B]
通讯作者:
Dupont,B
共 8 条
NK RECEPTOR FUNCTION IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION
-
批准号:7318389
-
项目类别:
-
资助金额:$22.83万
-
财政年份:2007
-
负责人:Bo Dupont
-
依托单位:
GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS
-
批准号:7318394
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2007
-
负责人:Bo Dupont
-
依托单位:
Natural Killer Cell Immune Synapse
-
批准号:6479000
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2002
-
负责人:Bo Dupont
-
依托单位:
Natural Killer Cell Immune Synapse
-
批准号:6865407
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2002
-
负责人:Bo Dupont
-
依托单位:
Natural Killer Cell Immune Synapse
-
批准号:6706321
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2002
-
负责人:Bo Dupont
-
依托单位:
Natural Killer Cell Immune Synapse
-
批准号:6625786
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2002
-
负责人:Bo Dupont
-
依托单位:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
-
批准号:6336332
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2000
-
负责人:Bo Dupont
-
依托单位:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
-
批准号:6203038
-
项目类别:
-
资助金额:$24.52万
-
财政年份:1999
-
负责人:Bo Dupont
-
依托单位:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
-
批准号:6102007
-
项目类别:
-
资助金额:$24.52万
-
财政年份:1998
-
负责人:Bo Dupont
-
依托单位:
GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS
-
批准号:8245885
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1998
-
负责人:Bo Dupont
-
依托单位:
NK RECEPTOR FUNCTION IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION
-
批准号:8245880
-
项目类别:
-
资助金额:$26.95万
-
财政年份:1998
-
负责人:Bo Dupont
-
依托单位:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
-
批准号:6236542
-
项目类别:
-
资助金额:$29.24万
-
财政年份:1997
-
负责人:Bo Dupont
-
依托单位:
CD28 MEDIATED ACTIVATION SIGNALS
-
批准号:2073988
-
项目类别:
-
资助金额:$24.79万
-
财政年份:1995
-
负责人:Bo Dupont
-
依托单位:
CD28 MEDIATED ACTIVATION SIGNALS
-
批准号:2073986
-
项目类别:
-
资助金额:$25.48万
-
财政年份:1995
-
负责人:Bo Dupont
-
依托单位:
CD28 MEDIATED ACTIVATION SIGNALS
-
批准号:2457814
-
项目类别:
-
资助金额:$25.79万
-
财政年份:1995
-
负责人:Bo Dupont
-
依托单位:
SERINE ESTERASES IN HUMAN CYTOLYTIC LYMPHOCYTES
-
批准号:3193045
-
项目类别:
-
资助金额:$26.71万
-
财政年份:1989
-
负责人:Bo Dupont
-
依托单位:
SERINE ESTERASES IN HUMAN CYTOLYTIC LYMPHOCYTES
-
批准号:3193046
-
项目类别:
-
资助金额:$27.6万
-
财政年份:1989
-
负责人:Bo Dupont
-
依托单位:
INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE
-
批准号:3433491
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1987
-
负责人:Bo Dupont
-
依托单位:
MOLECULAR GENETIC BASIC FOR HLA POLYMOPHISM
-
批准号:3134703
-
项目类别:
-
资助金额:$15.2万
-
财政年份:1985
-
负责人:Bo Dupont
-
依托单位:
IMMUNOGENETICS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
-
批准号:3093004
-
项目类别:
-
资助金额:$74.28万
-
财政年份:1978
-
负责人:Bo Dupont
-
依托单位: